The stakes are high for psilocybin clinical trials — there’s a pressing need for a more effective medical solution in the fight against depression, especially treatment-resistant depression.

At least 30% of people living with depression don’t get any help from at least the first two medications they try. That’s what doctors call treatment-resistant depression. This condition can ...

While Rejoyn is approved for depression, "it is not designed as a standalone treatment," says King; the approval is as a supplement to existing treatments or therapy to improve their effectiveness.

Now a sub-study shows that there is also ... Sleeping for 2: Insomnia Therapy Reduces Postpartum Depression, Study Shows Oct. 31, 2024 — CBT for insomnia significantly reduces postpartum ...

"These latest results confirmed a positive profile for safety and efficacy similar to early studies with patients with depression and bipolar disorder, and the home-based therapy may facilitate ...

The trial excluded individuals with treatment-resistant depression, high suicide risk, or comorbid psychiatric disorders. Participants were randomly assigned to receive either sham or active tDCS ...

We also discuss pharmacologic and psychotherapeutic treatment strategies for the management of depression in the patient with cancer. Cancer is diagnosed in over 1 million Americans each year.

Read on to learn more about PTSD and depression, as well as treatment options you may consider for both. Research suggests that people with PTSD are more likely to have depression. Deciphering ...

This, combined with data on psychiatric treatment outcome mediators, suggests that earlier intervention with ketamine could improve outcomes for patients suffering from refractory depression. The past ...